DIRS.INFO The most relevant business & tech news

Oxford scientist Adrian Hill said Ghana's drug regulator has approved the vaccine domestically for the age group at highest risk of death from malaria - children aged 5 months to 36 months. Oxford has a deal with Serum Institute of India to produce up to 200 million doses of the vaccine - known as R21 - annually. "This shows how close the world is to having a second approved vaccine to fight malaria," he said. MEETING THE NEEDThe first malaria vaccine, Mosquirix from British drugmaker GSK (GSK.L), was endorsed by the WHO last year after decades of work. Since it began in 2019, 1.2 million children across the three countries have received at least one dose of the Mosquirix vaccine.

The company — which has its COVID-19 vaccine as the only marketed product after 35 years in business — on Tuesday flagged significant uncertainty around its 2023 revenue, funding from the U.S. government, and pending arbitration with global vaccine alliance Gavi. Syringes with needles are seen in front of a displayed Novavax logo in this illustration taken, November 27, 2021. Novavax faces near-term risks as protein-based vaccines take longer to produce than mRNA-based competitors, Novavax CEO John Jacobs has said. "While there is the potential for a substantial booster market ... we don't expect Novavax to be a major player in the booster opportunity." As of last close, Novavax's U.S.-listed shares were down 97% from their February 2021 record high of $331.68.

☆ Novavax stock plunges 25% after the COVID-19 vaccine maker warns it could go out of business
▼ + stars: | 2023-03-01 | by ( Zinya Salfiti | ) www.businessinsider.com time to read: +2 min

Novavax shares sank 25% after it said it has "substantial doubt" about its ability to stay in business. The biotech plans spending cuts after it fourth-quarter loss was twice as deep as analysts expected. "Given these uncertainties, substantial doubt exists regarding our ability to continue as a going concern through one year from the date that these financial statements are issued," Novavax said in a statement Tuesday. The warning came as the Maryland-based company reported a fourth-quarter earning loss that was nearly twice as bad as some analysts had predicted. The company said it plans to focus on delivering an updated COVID-19 vaccine for the fall of 2023, as required by regulators to adapt to new strains of the coronavirus.

The stock had dropped 26.2% to $6.83 around 8:55 ET (13:55 GMT), while its Frankfurt-listed shares slumped more than 27%. The company - whose COVID vaccine is its only marketed product after 35 years in business - on Tuesday flagged significant uncertainty around its 2023 revenue, funding from the U.S. government, and pending arbitration with global vaccine alliance Gavi. Syringes with needles are seen in front of a displayed Novavax logo in this illustration taken, November 27, 2021. Novavax faces near-term risks as protein-based vaccines take longer to produce than mRNA-based competitors, Novavax CEO John Jacobs has said. As of last close, Novavax's U.S.-listed shares are down 97% from their February 2021 record high of $331.68.

☆ Novavax raises doubts about ability to remain in business, shares fall
▼ + stars: | 2023-02-28 | by ( Michael Erman | ) www.reuters.com time to read: +5 min

The company lost $182 million, or $2.28 per share, in the fourth quarter on weaker-than-expected sales of $357 million. Novavax's shares closed at $9.26 on Tuesday and fell to $6.90 in extended trading after reporting on its financial situation. "We're in the process of assessing the global footprint of Novavax, rationalizing our supply chain, rationalizing the portfolio and rationalizing the company structure and our infrastructure," he said. In the U.S., where the Novavax vaccine was authorized in July 2022, only around 80,000 of its shots have been administered. Jacobs said that while Novavax's vaccine may take longer to manufacture than its rivals from Pfizer (PFE.N)/BioNTech (22UAy.DE) and Moderna (MRNA.O), he believes FDA regulators want a protein-based option this fall for U.S. citizens.

☆ Novavax raises doubts about its ability to remain in business
▼ + stars: | 2023-02-28 | by ( Michael Erman | ) www.reuters.com time to read: +4 min

NEW YORK, Feb 28 (Reuters) - COVID-19 vaccine maker Novavax Inc (NVAX.O) on Tuesday raised doubts about its ability to remain in business and announced plans to slash spending as it works to prepare for a fall vaccination campaign. The company lost $182 million, or $2.28 per share, in the fourth quarter on weaker-than-expected sales of $357 million. "We're in the process of assessing the global footprint of Novavax, rationalizing our supply chain, rationalizing the portfolio and rationalizing the company structure and our infrastructure," he said. In the U.S., where the Novavax vaccine was authorized in July 2022, only around 80,000 of its shots have been administered. Jacobs said that while Novavax's vaccine may take longer to manufacture than its rivals from Pfizer (PFE.N)/BioNTech (22UAy.DE) and Moderna (MRNA.O), he believes FDA regulators want a protein-based option this fall for U.S. citizens.

☆ Novavax shares plunge as company raises doubts about its ability to remain in business
▼ + stars: | 2023-02-28 | by ( ) www.cnbc.com time to read: +4 min

A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Covid-19 vaccine maker Novavax on Tuesday raised doubts about its ability to remain in business and announced plans to slash spending as it works to prepare for a fall vaccination campaign. The company lost $182 million, or $2.28 per share, in the fourth quarter on weaker-than-expected sales of $357 million. "We're in the process of assessing the global footprint of Novavax, rationalizing our supply chain, rationalizing the portfolio and rationalizing the company structure and our infrastructure," he said. In the U.S., where the Novavax vaccine was authorized in July 2022, only around 80,000 of its shots have been administered.

☆ Fact Check-Moderna CEO did not say company made 100,000 COVID-19 vaccine doses before the pandemic started
▼ + stars: | 2023-02-10 | by ( Reuters Fact Check | ) www.reuters.com time to read: +4 min

At Davos 2023, Moderna CEO Stephane Bancel spoke about how quickly the company was able to scale up vaccine production at the start of the COVID-19 pandemic, not that Moderna had made 100,000 COVID vaccine doses before the pandemic began, as some are claiming online. The clip of Bancel responding to a question in January 2023 circulated in a tweet by the user @healthbyjames with the false caption, “URGENT — Moderna CEO Stéphane Bancel Admits Company Produced 100,000 COVID-19 Vaccine Doses In 2019 Before The Pandemic Started” (here). Bancel responds by first recalling that, “when the pandemic happened, Moderna had made 100,000 dose in 2019 for the whole year. Moderna did not produce 100,000 doses of the COVID-19 vaccine in 2019, Ridley said. Moderna CEO Stephane Bancel did not say in a 2023 panel discussion that the company produced 100,000 COVID-19 vaccines prior to the pandemic.

☆ Barcelona ease to 3-1 victory over Real Madrid to win Super Cup
▼ + stars: | 2023-01-15 | by ( ) www.reuters.com time to read: +2 min

Jan 15 (Reuters) - Barcelona were crowned Spanish Super Cup champions after goals from Gavi, Robert Lewandowski and Pedri earned them a 3-1 win over bitter rivals Real Madrid in Saudi Arabia on Sunday. Barcelona were dominant in every aspect of the game and took advantage of three mistakes by Real Madrid to score. Lewandowski extended the lead 12 minutes later on the counter when defender Dani Carvajal was caught out of position and left Gavi alone on the left wing. Real Madrid, who had no shots on target in the first half, spent most of the second in panic mode, trying to avoid a bigger defeat. Substitute Dani Ceballos lost the ball in midfield and Gavi sprinted forward and crossed for Pedri to fire point-black into the empty net.

☆ Morocco's 'avocado head' plots another World Cup shock
▼ + stars: | 2022-12-04 | by ( Shady Amir | ) www.reuters.com time to read: +2 min

Spain, who humbled Costa Rica 7-0 in their opening game, finished second in Group E behind Japan while Morocco defied the odds to win Group F ahead of Croatia and Belgium. The Spanish, world champions in 2010, lost their last group match to Japan and face a difficult test from a Moroccan side growing in confidence under coach Walid Regragui. Spain drew 1-1 with Germany following their rout of Costa Rica and after the loss to Japan coach Luis Enrique was critical of his team. This was impossible because in five minutes, Japan scored two goals ... we were out, we were dismantled," he said. In the first half against Costa Rica, Spain's 537 successful passes set a World Cup record but they will need to show more cutting edge to stay on course for a second world title.

☆ Spain make one change in defence, Germany replace Havertz
▼ + stars: | 2022-11-27 | by ( Steve Keating | Hritika Sharma | ) www.reuters.com time to read: +1 min

AL KHOR, Qatar, Nov 27 (Reuters) - Spain coach Luis Enrique made one change to his starting lineup against Germany in their World Cup Group E on Sunday following their opening 7-0 demolition of Costa Rica, with Dan Carvajal replacing Cesar Azpilicueta in defence. The Spaniards, who will all but qualify with a win over the Germans, were otherwise unchanged in attack with Dani Olmo, Feran Torres and Marco Asensio. Germany, who suffered a shock opening loss to Japan and are in desperate need of points, brought on fullback Thilo Kehrer in the place of Nico Schlotterbeck. Coach Hansi Flick also dropped forward Kai Havertz, boosting his midfield with Leon Goretzka. Reporting by Karolos Grohmann; Editing by Angus MacSwanOur Standards: The Thomson Reuters Trust Principles.

☆ Germany look for great escape against Spain to avoid early exit
▼ + stars: | 2022-11-25 | by ( Karolos Grohmann | ) www.reuters.com time to read: +2 min

They have conceded six goals in their last four internationals but now have to find a way to shut out Spain, who fired seven past Costa Rica in their group opener. Germany backed down despite a promise to wear it only 48 hours prior to their game. Spain, on the other had, have none of the pressure their European counterparts are feeling. After years of being expected to deliver titles, Spain have entered the tournament with a lighter load on their shoulders under coach Luis Enrique and have already set records. Barcelona's 18-year-old Gavi became the country's youngest World Cup player, and the youngest to score since Brazil great Pele in 1958 after netting in their 7-0 win over Costa Rica.

☆ World Cup 2022 - Germany 1-2 Japan: Late Ritsu Doan and Takuma Asano goals earn shock victory
▼ + stars: | 2022-11-24 | by ( Charlotte Marsh | ) www.cnbc.com time to read: +11 min

Japan celebrates during a FIFA World Cup Qatar 2022 Group E match against Germany at Khalifa International Stadium on Nov. 23, 2022 in Doha, Qatar. Marc Atkins | Getty Images Sport | Getty ImagesEach Japan goal was greeted with a team bundle at the corner flag, and there were joyous celebrations at full-time. For Germany, their poor World Cup form continues, having finished bottom of their group at the 2018 tournament. After having two earlier efforts blocked, Gundogan stepped up and expertly dispatched his spot-kick to see the four-time World Cup winners in front. We made mistakes that we should never commit especially in a World Cup and those are the things that we need to improve on."

☆ Gavi rejects Novavax's claim on COVID vaccine deal breach
▼ + stars: | 2022-11-22 | by ( ) www.reuters.com time to read: +2 min

Nov 22 (Reuters) - Global vaccine alliance Gavi on Tuesday rejected Novavax's (NVAX.O) claim that the group had breached an advance purchase agreement to procure 350 million doses of the company's COVID-19 vaccine. Novavax also has a pact with Serum Institute of India for manufacturing a version of the vaccine under the brand Covovax, which would also be supplied to the COVAX facility. Gavi's spokesperson said Serum Institute had a 300 million dose commitment for Covovax, with options for 750 million more doses if needed. A spokesperson for Serum Institute declined to comment. Novavax recently cut its full-year forecast yet again, hurt by late authorizations of its COVID vaccine globally amid a waning demand for shots.

☆ Group's E and F get underway with Belgium, Germany and Spain in action
▼ + stars: | 2022-11-22 | by ( Ben Morse | ) edition.cnn.com time to read: +5 min

Germany will face a Japan team full of names familiar to fans around the world. For Costa Rica, it is a last hurrah for some of the country’s legendary players. So, with one final shot at glory, Belgium begin against a Canada side making its second appearance at a World Cup. Canada ended its 36-year drought to play in a World Cup when it qualified earlier this year. ETSpain vs. Costa Rica: 11 a.m.

☆ Novavax ends COVID vaccine sale agreement with Gavi
▼ + stars: | 2022-11-21 | by ( ) www.reuters.com time to read: +2 min

Nov 21 (Reuters) - Novavax Inc (NVAX.O) said on Monday it had delivered a written notice to Gavi, the Vaccine Alliance, terminating with immediate effect an agreement for the sale of the company's COVID-19 vaccine to low- and middle-income countries. The company cited Gavi's failure to procure the 350 million doses it had agreed to buy in May last year for the COVAX facility. Novavax received a non-refundable advance payment of $350 million from Gavi last year and an additional $350 million this year after the vaccine got the WHO's emergency use listing, the company said. The company had earlier this month cut its full-year forecast yet again, hurt by late authorizations of its vaccine globally. Covovax and Serum's vaccines were the ninth and tenth vaccine, respectively, to get the WHO's emergency listing.

☆ Fati on target as Spain warm-up with win over Jordan
▼ + stars: | 2022-11-17 | by ( ) www.reuters.com time to read: +1 min

AMMAN, Nov 17 (Reuters) - Ansu Fati seized his chance to impress Spain manager Luis Enrique as the Barcelona youngster scored in his side's 3-1 victory over Jordan in a World Cup warm-up on Thursday. With all eyes on Fati after doubts over whether he would make the 26-man squad, he looked lively and was off target with another couple of attempts as a Spanish side featuring several fringe players dominated. Spain made a host of changes after the break with Robert Sanchez replaced in goal by David Raya who was called into action to keep out a fine effort by Mahmoud Mardi. Youngster Nico Williams, who replaced Fati late on, did his cause no harm with a well-taken third in the 84th minute. Spain blotted their copybook as Jordan managed a late consolation through substitute Hamza Al Dardour after a mistake by substitute Cesar Azpilicueta.

☆ Spain at the 2022 World Cup: who is in Luis Enrique's 26-man squad?
▼ + stars: | 2022-11-14 | by ( ) www.reuters.com time to read: +4 min

Nov 14 (Reuters) - Spain are looking to win their second World Cup title at the Nov. 20-Dec. 18 tournament in Qatar. WHO IS IN SPAIN'S WORLD CUP 2022 SQUAD? * Defenders: Jordi Alba (Barcelona), Nacho Monreal (Arsenal), Alvaro Odriozola (Real Sociedad), Nacho Fernandez (Real Madrid), Dani Carvajal (Real Madrid), Gerard Pique (Barcelona), Sergio Ramos (Real Madrid), Cesar Azpilicueta (Chelsea). * Midfielders: Sergio Busquets (Barcelona), Isco (Real Madrid), Thiago Alcantara (Bayern Munich), David Silva (Manchester City), Andres Iniesta (Barcelona), Saul Niguez (Atletico Madrid), Koke (Atletico Madrid). * Forwards: Marco Asensio (Real Madrid), Iago Aspas (Celta Vigo), Diego Costa (Atletico Madrid), Rodrigo Moreno (Valencia), Lucas Vazquez (Real Madrid).

☆ Fati in but Thiago and De Gea left out of Spain World Cup squad
▼ + stars: | 2022-11-11 | by ( Fernando Kallas | ) www.reuters.com time to read: +3 min

MADRID, Nov 11 (Reuters) - Spain included Barcelona's Ansu Fati but left out Liverpool midfielder Thiago Alcantara and Manchester United goalkeeper David de Gea from their 26-man World Cup squad on Friday. But the forward is fighting his way back from four surgeries to repair an injury to his left knee, suffered in November 2020. "Youth gives you freedom because you are not yet aware of the consequences," Luis Enrique said. "There's no one outside of Spain who rules out Spain as a candidate to be among the best. Midfielders: Sergio Busquets (Barcelona), Rodri Hernandez (Manchester City), Gavi (Barcelona), Carlos Soler (Paris St Germain), Marcos Llorente (Atletico Madrid), Pedri Gonzalez (Barcelona), Koke Resurreccion (Atletico Madrid).

In the West, only about 10 people have died of monkeypox this year, figures from the U.S. CDC show. No monkeypox vaccines are publicly available in Africa. But those failures are being repeated a year on with monkeypox, the health workers consulted by Reuters said. Congo health minister Jean-Jacques Mbungani told Reuters Congo was in talks with the WHO to buy vaccines, but no formal request had been made. A WHO spokeswoman said that in the absence of available vaccines, countries should instead focus on surveillance and contact tracing.

Dozens of measles cases have cropped up in Gambia this year, a spike over previous years. The measles campaign was rescheduled for 2021, but in July of that year polio was detected in a water sample. Over the years, the success of the measles vaccine has numbed many to these risks, health experts say. At the time, 86% of children had at least the first dose of the measles vaccine worldwide, according to WHO estimates. FUNDS REJECTEDThe U.S. CDC has identified 12 African countries as having no clear plans or secured resources for their next measles vaccination drive.

☆ Benzema, Putellas win Ballon d'Or awards for best soccer players in the world
▼ + stars: | 2022-10-17 | by ( Julien Pretot | ) www.reuters.com time to read: +4 min

Summary Real Madrid's Frenchman Benzema voted best men's playerBarca's Spain midfielder Putellas picks up women's awardpep Guardiola's Manchester City chosen as Best ClubPARIS, Oct 17 (Reuters) - Real Madrid's France forward Karim Benzema won the 2022 Ballon d'Or award for the best men's player in the world on Monday, while Barcelona's Spain midfielder Alexia Putellas won the women's award for a second time. Benzema had a stellar season with Real, scoring 44 goals in 46 games in all competitions as he helped guide them to a LaLiga and Champions League double. His 15 goals in the Champions League guided Real to a record-extending 14th title. Putellas, who was also named FIFA Best Women's Player earlier this year, was top scorer in the Champions League last season with 11 goals and scored 18 in the Primera Division. However, the teams in the Champions League final lost out on the Best Club award, which went to Pep Guardiola's Manchester City who won a fourth Premier League title in five years.

☆ U.S. cutting global donations of Pfizer COVID shots as demand slows
▼ + stars: | 2022-09-22 | by ( Michael Erman | ) www.reuters.com time to read: +2 min

REUTERS/Rodrigo GarridoNEW YORK, Sept 22 (Reuters) - The United States is significantly cutting back the number of Pfizer (PFE.N)/BioNTech (22UAy.DE) COVID-19 vaccine doses it will buy for donation to poorer nations this year, Pfizer said on Thursday, citing diminished demand for the shots in those countries. The United States will have an option to buy up to an additional 400 million shots for the program after this year. Pfizer said it had already delivered 400 million vaccine doses in 79 countries under the U.S. government contract. The vaccine doses were donated through the COVAX program, run by the World Health Organization and GAVI global vaccine alliance, which was intended to deliver COVID-19 shots to the world's poorer countries. COVAX has been negotiating since june with vaccine manufacturers to cut or slow deliveries of 400 million to 600 million vaccine doses from its own contracts.

☆ Deadly childhood diseases rise in Ethiopia's Tigray as war hampers vaccinations
▼ + stars: | 2022-09-20 | by ( ) www.reuters.com time to read: +5 min

The percentage of children in Tigray receiving routine vaccines has fallen below 10% this year, data from the Tigray Health Bureau shows, undoing years of government efforts to boost immunisation rates. read moreMEASLES OUTBREAKSHealth Minister Lia Tadesse said vaccines had been provided to Tigray this year and that more were ready to be delivered once conditions allowed. The rate across Ethiopia was 65% in 2021, according to data from the U.N. children's agency UNICEF. Ethiopia's health minister Lia said 860,000 doses of measles vaccines were delivered to Tigray last December and additional doses were delivered on April 2. WFP spokesperson Claire Nevill, however, said the agency was waiting on clearances from Ethiopia's government.

☆ GAVI financing to allow for immediate funds for next pandemic
▼ + stars: | 2022-09-20 | by ( Michael Erman | ) www.reuters.com time to read: +3 min

Berkley said that in 2020 and 2021, GAVI was limited in its ability to buy COVID-19 vaccines because even though donors had committed $2.4 billion, the vaccine alliance only had $400 million in cash on hand. GAVI and the World Health Organization ran the global COVAX program intended to deliver COVID-19 vaccines to the world's poorer countries. COVAX has delivered more than 1.72 billion vaccine doses to 146 countries. COVAX has been negotiating since June with vaccine manufacturers to cut or slow deliveries of 400 million to 600 million vaccine doses. read more COVAX already has 300 to 400 million COVID-19 vaccine doses available if countries need more supply, Berkley said.

Search resuls for: "GAVI"

25 mentions found